Hidehiko Matsukawa

Novel vasopressin V2 receptor-selective antagonists, pyrrolo[2,1-a]quinoxaline and pyrrolo[2,1-c][1,4]benzodiazepine derivatives

Yasuhiro OHTAKE, Akira Naito, Hisashi Hasegawa et al. · Bioorganic & Medicinal Chemistry · 1999 · 49 citations

Medicine, Medicinal Chemistry, Pharmacology +4

Identification of connexins in human oral mucosa and therapeutic effect of irsogladine maleate on aphthous stomatitis

Toshiya Murata, Ryuichiro Uemura, Toshiyuki Miura et al. · Journal of Gastroenterology · 1999 · 25 citations

Dentistry, Oral Biology, Oral Medicine +11

The use of infliximab in the prevention of postsurgical recurrence in polysurgery Crohn's disease patients: a pilot open-labeled prospective study

Atsushi Sakuraba, Toshiro Sato, Hidehiko Matsukawa et al. · International Journal of Colorectal Disease · 2012 · 22 citations

Medicine, Pharmacotherapy, Surgery +14

Histopathological insights into hair loss in <scp>C</scp>ronkhite–<scp>C</scp>anada syndrome: Diffuse anagen‐telogen conversion precedes clinical hair loss progression

Emiko Watanabe‐Okada, Toyoko Inazumi, Hidehiko Matsukawa et al. · Australasian Journal of Dermatology · 2013 · 20 citations

Medicine, Dermatology, Pathology +17

Characterization of a Novel Aldose Reductase Inhibitor, TAT, and Its Effects on Streptozotocin-Induced Diabetic Neuropathy in Rats

Shinji Inukai, Mitsuji Agata, Manami Sato et al. · The Japanese Journal of Pharmacology · 1993 · 14 citations · Full text

Medicine, Biochemistry, Pharmacology +15